Table 3 |
||||||
|
Comparison between national reference laboratories and CENQAM Reference laboratory regarding the quality screening of AM drugs |
||||||
| CENQAM % fulfilling the USP content criteria |
Sana'a DQCL % fulfilling the USP content criteria |
P1-value |
Aden DQCL % fulfilling the USP content criteria |
P2-value |
P3-value |
|
|
|
||||||
| CQS Assay |
93.3 (14/15) |
100 (15/15) |
1 |
100 (15/15) |
1 |
1 |
| CQT Assay |
80 (20/25) |
92 (23/25) |
0.41 |
84 (21/25) |
1 |
0.66 |
| CQT dissolution |
92 (23/25) |
100 (25/25) |
0.47 |
96 (24/25) |
1 |
1 |
| SP Assay |
100 (10/10) |
100 (10/10) |
1 |
100 (10/10) |
0 |
1 |
| SPT dissolution |
20 (2/10) |
100 (10/10) |
0.005* |
100 (10/10) |
0.005* |
1 |
|
|
||||||
|
P1: p-value of Chi-Square test for comparing the proportion of tested products fulfilling the USP content criteria in CENQAM versus Sana'a reference laboratory. P2: p-value of Chi-Square test for comparing the proportion of tested products fulfilling the USP content criteria in CENQAM versus Aden reference laboratory. P3: p-value of Chi-Square test for comparing the proportion of tested products fulfilling the USP content criteria in Sana'a versus Aden reference laboratory. |
||||||
|
Abdo-Rabbo et al. Malaria Journal 2005 4:28 doi:10.1186/1475-2875-4-28 |
||||||
